ACTINIUM PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable, Related Parties
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Increase (Decrease) in Accounts Payable, Related Parties of $50.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2018-08-09
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2015-12-31 was -$13.54K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2015-09-30 was $13.54K, a 84.75% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2015-06-30 was -$282.91K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2015-03-31 was $93.56K, a 13.66% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2015 was -$189.36K, a 242.19% decline from fiscal 2014.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2014 was $133.17K, a 166.34% increase from fiscal 2013.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2013 was $50.00K, a 60.33% increase from fiscal 2012.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2012 was $31.18K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month | Increase (Decrease) in Accounts Payable, Related Parties 151 month | Increase (Decrease) in Accounts Payable, Related Parties 154 month | Increase (Decrease) in Accounts Payable, Related Parties 157 month | Increase (Decrease) in Accounts Payable, Related Parties 160 month | Increase (Decrease) in Accounts Payable, Related Parties 163 month | Increase (Decrease) in Accounts Payable, Related Parties 166 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | $50.00K 10-Q · filed 2018-08-09 | |||||||||
| 2016-06-30 | $60.15K 10-Q · filed 2017-08-04 | |||||||||
| 2015-12-31 | -$13.54K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | -$282.91K derived: sum of 3 quarters · filed 2018-03-16 | -$189.36K 10-K · filed 2018-03-16 | ||||||
| 2015-09-30 | $13.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$269.37K derived: sum of 2 quarters · filed 2016-10-28 | -$175.82K 10-Q · filed 2016-10-28 | -$239.75K derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2015-06-30 | -$282.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | -$189.36K 10-Q · filed 2016-07-29 | -$253.29K derived: sum of 3 quarters · filed 2017-03-16 | -$164.54K derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2015-03-31 | $93.56K 10-Q · filed 2016-05-10 | $29.62K derived: sum of 2 quarters · filed 2017-03-16 | $118.38K derived: sum of 3 quarters · filed 2017-03-16 | $118.38K derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2014-12-31 | -$63.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $24.82K derived: sum of 2 quarters · filed 2017-03-16 | $24.82K derived: sum of 3 quarters · filed 2017-03-16 | $133.17K 10-K · filed 2017-03-16 | ||||||
| 2014-09-30 | $88.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $88.75K derived: sum of 2 quarters · filed 2015-10-30 | $197.11K 10-Q · filed 2015-10-30 | -$97.39K derived: sum of 4 quarters · filed 2016-03-11 | ||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $108.35K 10-Q · filed 2015-08-07 | -$186.15K derived: sum of 3 quarters · filed 2016-03-11 | |||||||
| 2014-03-31 | $108.35K 10-Q · filed 2015-05-08 | -$186.15K derived: sum of 2 quarters · filed 2016-03-11 | $189.54K 10-Q · filed 2014-05-12 | |||||||
| 2013-12-31 | -$294.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $50.00K 10-K · filed 2016-03-11 | $81.19K 10-K · filed 2014-02-28 | |||||||
| 2013-09-30 | $344.50K 10-Q · filed 2014-10-31 | $375.69K 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | $31.18K 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $31.18K 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | $29.09K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $31.18K 10-K · filed 2014-02-28 | $31.18K 10-K · filed 2013-03-29 | |||||||
| 2012-09-30 | $2.10K 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |